Developing and evaluating stereotactic lung RT trials: what we should know about the influence of inhomogeneity corrections on dose-3

L plan.<p><b>Copyright information:</b></p><p>Taken from "Developing and evaluating stereotactic lung RT trials: what we should know about the influence of inhomogeneity corrections on dose"</p><p>http://www.ro-journal.com/content/3/1/21</p><p>Radiation Oncology (London, England) 2008;3():21-21.</p><p>Published online 28 Jul 2008</p><p>PMCID:PMC2515326.</p><p>